Evidence map›Paper›PMID 37614970›Full record

ArticleMicrosystems & nanoengineering2023

Double-antibody-based nano-biosensing system for the onsite monitoring of SARS-CoV-2 variants.

Heba A Hussein, Ahmed Kandeil, Mokhtar Gomaa, Rabeay Y A Hassan

Open access · goldAbstract read
In one paragraph

Article in Microsystems & nanoengineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Polypyrrole functionalized (TiRSC advances · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Heba A HusseinVirology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Giza, 12619 Egypt.
Ahmed KandeilCenter of Scientific Excellence for Influenza Viruses, Environmental Research Division, National Research Centre, Giza, 12622 Egypt.
Mokhtar GomaaCenter of Scientific Excellence for Influenza Viruses, Environmental Research Division, National Research Centre, Giza, 12622 Egypt.
Rabeay Y A HassanBiosensors Research Laboratory, Zewail City of Science and Technology, 6th October City, Giza, 12578 Egypt.ORCID 0000-0002-1867-9643
National Influenza Center · MNZewail City of Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fast and reliable diagnosis of COVID-19 is the foremost priority for promoting public health interventions. Therefore, double-antibody-based immunobiosensor chips were designed, constructed, and exploited for clinical diagnosis. Gold nanoparticles/tungsten oxide/carbon nanotubes (AuNPs/WO

Indexed as

ChemistryEnvironmental, health and safety issues

Identifiers

PMID37614970
PMCPMC10442362
OpenAlexW4386029475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.